Sakura Bio is a cell therapy company developing SAK (super activated killer). This is an off the shelf, allogenic T-cell therapy produce via a simple, relatively shot manipulation of naïve PBMC. Comprehensive preclinical studies validated the superiority of SAK vs. other Cell therapy solutions as a perfect therapy for many cancers but in particular in acute myeloid leukemia (AML).
